LeMaitre (LMAT)
Makes vascular grafts, patches, and shunts while providing human-tissue cryopreservation services.
$80.98
After-hours close0.00 (0.00%)
At close$80.98(+2.25%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47 | 49 | 53 | 56 | 55 | 56 | 60 | 64 | 61 | 64 | 67 | 70 |
| Cost of revenue | 17 | 16 | 17 | 17 | 18 | 17 | 18 | 19 | 15 | 18 | 18 | 20 |
| Gross profit | 31 | 33 | 37 | 38 | 37 | 39 | 41 | 45 | 46 | 46 | 48 | 51 |
| 22 | 23 | 25 | 24 | 24 | 26 | 29 | 29 | 26 | 27 | 31 | 30 | |
| Research & development | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 5 |
| 17 | 19 | 21 | 20 | 20 | 22 | 25 | 25 | 23 | 24 | 27 | 26 | |
| Selling & marketing | 10 | 10 | 12 | 11 | 11 | 13 | 14 | 15 | 12 | 13 | 15 | 14 |
| General & administrative | 8 | 8 | 9 | 9 | 9 | 9 | 10 | 10 | 11 | 10 | 12 | 11 |
| Operating income | 9 | 10 | 12 | 14 | 13 | 13 | 13 | 16 | 20 | 19 | 18 | 20 |
| 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | |
| Interest income | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 3 | 3 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | 0 | −2 | −1 | −1 | −1 | −5 | −3 | −3 | −4 | −3 | −3 | 3 |
| Income before tax | 10 | 11 | 13 | 16 | 15 | 14 | 14 | 18 | 23 | 20 | 20 | 22 |
| Income tax expense | 2 | 3 | 3 | 4 | 3 | 3 | 3 | 4 | 5 | 5 | 4 | 5 |
| Net income from continuing operations | 8 | 8 | 10 | 12 | 11 | 11 | 11 | 14 | 17 | 16 | 16 | 17 |
| Net income | 8 | 8 | 10 | 12 | 11 | 11 | 11 | 14 | 17 | 16 | 16 | 17 |
| EPS, basic | $0.34 | $0.38 | $0.43 | $0.53 | $0.50 | $0.50 | $0.49 | $0.61 | $0.77 | $0.69 | $0.69 | $0.75 |
| EPS, diluted | $0.33 | $0.38 | $0.43 | $0.52 | $0.49 | $0.49 | $0.48 | $0.60 | $0.75 | $0.68 | $0.68 | $0.74 |
| Weighted average shares, basic | 22 | 22 | 22 | 22 | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Weighted average shares, diluted | 22 | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 24 | 23 | 23 | 25 |
| EBITDA | 12 | 15 | 15 | 18 | 17 | 20 | 18 | 22 | 26 | 24 | 24 | 23 |
| Depreciation & amortization | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 6 |
| EBIT | 9 | 12 | 13 | 16 | 15 | 18 | 16 | 19 | 24 | 22 | 21 | 17 |